Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche

Neurodegenerative disorders are one of the leading causes of death and disability and one of the biggest burdens on health care systems. Novel approaches using various types of stem cells have been proposed to treat common neurodegenerative disorders such as Alzheimer’s Disease, Parkinson’s Disease,...

Full description

Saved in:
Bibliographic Details
Main Authors: Alejandro Luarte, Luis Federico Bátiz, Ursula Wyneken, Carlos Lafourcade
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2016/5736059
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553040644669440
author Alejandro Luarte
Luis Federico Bátiz
Ursula Wyneken
Carlos Lafourcade
author_facet Alejandro Luarte
Luis Federico Bátiz
Ursula Wyneken
Carlos Lafourcade
author_sort Alejandro Luarte
collection DOAJ
description Neurodegenerative disorders are one of the leading causes of death and disability and one of the biggest burdens on health care systems. Novel approaches using various types of stem cells have been proposed to treat common neurodegenerative disorders such as Alzheimer’s Disease, Parkinson’s Disease, or stroke. Moreover, as the secretome of these cells appears to be of greater benefit compared to the cells themselves, the extracellular components responsible for its therapeutic benefit have been explored. Stem cells, as well as most cells, release extracellular vesicles such as exosomes, which are nanovesicles able to target specific cell types and thus to modify their function by delivering proteins, lipids, and nucleic acids. Exosomes have recently been tested in vivo and in vitro as therapeutic conveyors for the treatment of diseases. As such, they could be engineered to target specific populations of cells within the CNS. Considering the fact that many degenerative brain diseases have an impact on adult neurogenesis, we discuss how the modulation of the adult neurogenic niches may be a therapeutic target of stem cell-derived exosomes. These novel approaches should be examined in cellular and animal models to provide better, more effective, and specific therapeutic tools in the future.
format Article
id doaj-art-261b82b21bcc4936bf6b436637bd6891
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-261b82b21bcc4936bf6b436637bd68912025-02-03T05:57:07ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/57360595736059Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic NicheAlejandro Luarte0Luis Federico Bátiz1Ursula Wyneken2Carlos Lafourcade3Laboratorio de Neurociencias, Facultad de Medicina, Universidad de Los Andes, Monseñor Alvaro del Portillo 12455, Las Condes, 7550000 Santiago, ChileCenter for Interdisciplinary Studies on the Nervous System (CISNe), Universidad Austral de Chile, Valdivia, ChileLaboratorio de Neurociencias, Facultad de Medicina, Universidad de Los Andes, Monseñor Alvaro del Portillo 12455, Las Condes, 7550000 Santiago, ChileLaboratorio de Neurociencias, Facultad de Medicina, Universidad de Los Andes, Monseñor Alvaro del Portillo 12455, Las Condes, 7550000 Santiago, ChileNeurodegenerative disorders are one of the leading causes of death and disability and one of the biggest burdens on health care systems. Novel approaches using various types of stem cells have been proposed to treat common neurodegenerative disorders such as Alzheimer’s Disease, Parkinson’s Disease, or stroke. Moreover, as the secretome of these cells appears to be of greater benefit compared to the cells themselves, the extracellular components responsible for its therapeutic benefit have been explored. Stem cells, as well as most cells, release extracellular vesicles such as exosomes, which are nanovesicles able to target specific cell types and thus to modify their function by delivering proteins, lipids, and nucleic acids. Exosomes have recently been tested in vivo and in vitro as therapeutic conveyors for the treatment of diseases. As such, they could be engineered to target specific populations of cells within the CNS. Considering the fact that many degenerative brain diseases have an impact on adult neurogenesis, we discuss how the modulation of the adult neurogenic niches may be a therapeutic target of stem cell-derived exosomes. These novel approaches should be examined in cellular and animal models to provide better, more effective, and specific therapeutic tools in the future.http://dx.doi.org/10.1155/2016/5736059
spellingShingle Alejandro Luarte
Luis Federico Bátiz
Ursula Wyneken
Carlos Lafourcade
Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche
Stem Cells International
title Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche
title_full Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche
title_fullStr Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche
title_full_unstemmed Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche
title_short Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche
title_sort potential therapies by stem cell derived exosomes in cns diseases focusing on the neurogenic niche
url http://dx.doi.org/10.1155/2016/5736059
work_keys_str_mv AT alejandroluarte potentialtherapiesbystemcellderivedexosomesincnsdiseasesfocusingontheneurogenicniche
AT luisfedericobatiz potentialtherapiesbystemcellderivedexosomesincnsdiseasesfocusingontheneurogenicniche
AT ursulawyneken potentialtherapiesbystemcellderivedexosomesincnsdiseasesfocusingontheneurogenicniche
AT carloslafourcade potentialtherapiesbystemcellderivedexosomesincnsdiseasesfocusingontheneurogenicniche